A progression risk assessment model for pulmonary ground-glass nodules based on traditional Chinese medicine clinical symptoms combined with imagingOA
A progression risk assessment model for pulmonary ground-glass nodules based on traditional Chinese medicine clinical symptoms combined with imaging
Ayidana Maolan;Xiao-ling Ren;Juan Li;Tian-heng Sun;Wei Yang;Rui Liu;Bao-jin Hua;Le-hua Yu;Yue Li;Zhao-shuai Yan;Xing-hua Xiang;Lin-feng Wang;Qiu-jun Guo;Jia-qi Hu;Guang-hui Zhang
Department of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China||School of Graduates,Beijing University of Chinese Medicine,Beijing 100029,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China||School of Graduates,Beijing University of Chinese Medicine,Beijing 100029,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,ChinaInstitute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 10070,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,ChinaInstitute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 10070,China||School of Mathematics and Statistics,Hunan University of Science and Technology,Changsha 411201,Hunan Province,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China||School of Graduates,Beijing University of Chinese Medicine,Beijing 100029,ChinaInstitute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 10070,China||Department of Mathematics and Physics,North China Electric Power University,Baoding 071003,Hebei Province,ChinaInstitute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 10070,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,ChinaDepartment of Oncology,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China||School of Graduates,Beijing University of Chinese Medicine,Beijing 100029,China
Artificial intelligenceCancer preventionTraditional Chinese medicineFeature fusionPulmonary ground-glass nodulesDisease progressionRisk assessment model
Artificial intelligenceCancer preventionTraditional Chinese medicineFeature fusionPulmonary ground-glass nodulesDisease progressionRisk assessment model
《结合医学学报（英文版）》 2026 (3)
376-386,11
This study was supported by Capital's Funds for Health Improvement and Research(No.2024-2-4153),the National Natu-ral Science Foundation of China(No.82274609 and No.82174465),the Scientific and Technological Innovation Project of China Acad-emy of Chinese Medical Sciences(No.CI2021A01808,No.CI2021A01810,No.CI2021B009,No.CI2021A04706 and No.CI2021B003),Noncommunicable Chronic Diseases-National Science and Technology Major Project(No.2023ZD0502500 and No.2023ZD0502502),and High-level Chinese Medical Hospital Promotion Project(No.HLCMHPP2023101 and No.HLCMHPP2023085).
评论